Enrico M A Fassi
ORCID: 0000-0001-6282-4273
· 1 paper in corpus
other
2023
Elagolix sodium salt is the first marketed orally active non-peptide gonadotropin-releasing hormone receptor antagonist (GnRHR-ant) for the management of hormone dependent diseases, such as endometriosis and uterine fibroids. Despite its pr…